Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_assertion type Assertion NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_head.
- NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_assertion description "[These results contribute to a deeper understanding of the properties of transgenic lymphocytes used to treat human malignancies and may provide a rationale for the development of combination therapies as a method to improve ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_provenance.
- NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_assertion evidence source_evidence_literature NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_provenance.
- NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_assertion SIO_000772 23861247 NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_provenance.
- NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_assertion wasDerivedFrom befree-20140225 NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_provenance.
- NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_assertion wasGeneratedBy ECO_0000203 NP333669.RA-wVU5Rr-9uQsAAiRzj7MX4b_jhAs-egk6tjdLWmH1ec130_provenance.